Peyman Hadji

6PUBLICATIONS
28CO-AUTHORS
Pacific Peoples midwifery and paediatricsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Major global burdens of diseasePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS.

|Jan 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

G Marcucci, E Biver, J J Body

|Aug 02, 2024
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER® and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk.

Peyman Hadji, Luka Kamali, Friederike Thomasius

|Jun 23, 2023
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Rebecca J Moon, Jean-Yves Reginster, Nasser M Al-Daghri

|Mar 25, 2022
Management of patients at very high risk of osteoporotic fractures through sequential treatments.

Elizabeth M Curtis, Jean-Yves Reginster, Nasser Al-Daghri

Pageof 1